Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
39.75 HKD | +1.53% | +19.73% | -7.02% |
Apr. 17 | Innovent Appoints Dr. Nageatte Ibrahim as the Oncology Chief Medical Officer | CI |
Apr. 02 | Hutchmed endometrial cancer treatment application accepted for review | AN |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-7.02% | 8.12B | |
-4.06% | 86.13B | |
+1.97% | 39.82B | |
+56.59% | 25.23B | |
-13.53% | 15.36B | |
-8.82% | 11.95B | |
-15.35% | 11.6B | |
-41.58% | 11.51B | |
+6.14% | 8.71B | |
+2.49% | 7.72B |
- Stock Market
- Equities
- 1801 Stock
- News Innovent Biologics, Inc.
- Innovent Biologics New Cancer Drug Gets NDA from Chinese Authority